H-MESO-1A Cells

The H-MESO-1A cell line is derived from human mesothelioma, a type of cancer that originates in the mesothelial cells lining the lungs, abdomen, or heart. This cell line is particularly valuable for research focused on understanding the pathophysiology of mesothelioma and the development of therapeutic strategies. Mesothelioma is often linked to asbestos exposure, and the H-MESO-1A cells can be used to study the molecular mechanisms underlying asbestos-induced carcinogenesis. H-MESO-1A cells exhibit the characteristic features of mesothelioma, including aggressive growth and resistance to conventional chemotherapy. They are utilized in preclinical studies to evaluate the efficacy of novel drugs, gene therapy approaches, and immunotherapy strategies. Researchers use this cell line to investigate the genetic and epigenetic alterations associated with mesothelioma, as well as to identify potential biomarkers for early diagnosis and prognosis. The H-MESO-1A cell line is an essential tool in the advancement of mesothelioma research and the quest for effective treatments.